GF Fund Management
ABVX icon

GF Fund Management’s Abivax ABVX Stock Holding History

GF Fund Management’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$140K Buy
1,417
+115
+9% +$13.9K ﹤0.01% 306
2026
Q2 		$174K Sell
1,302
-24
-2% -$2.72K ﹤0.01% 289
2026
Q1 		$148K Buy
1,326
+167
+14% +$19.8K ﹤0.01% 307
2025
Q4 		$156K Buy
+1,159
New +$126K ﹤0.01% 312

Other funds holding ABVX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Western Standard LLC
Western Standard LLC Los Angeles, California $424M AUM 17.4% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
CenterBook Partners
CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return
Nan Fung Trinity
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $483B AUM 41.26% 1-Year Est. Return

GF Fund Management's ABVX Position: Q3 2026 in Review

GF Fund Management increased its Abivax (ABVX) stake by 8.8% in Q3 2026, buying an estimated $13.9K and bringing the position to 1,417 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #306.

GF Fund Management first reported a position in ABVX in Q4 2025 and has held it in 4 quarters since. The position peaked at $174K in Q2 2026. 104 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • GF Fund Management held 1,417 shares of Abivax worth $140K as of Q3 2026.
  • GF Fund Management bought 115 Abivax shares in Q3 2026, an estimated $13.9K.
  • Abivax made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #306 holding.
  • GF Fund Management first reported a position in Abivax in Q4 2025 and has held it in 4 quarters since.
  • GF Fund Management's Abivax position peaked at $174K in Q2 2026.
  • 104 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.